Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C19H26Cl2N2O |
| Molecular Weight | 369.329 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CN([C@@H]1CCCC[C@H]1N2CCCC2)C(=O)CC3=CC=C(Cl)C(Cl)=C3
InChI
InChIKey=VQLPLYSROCPWFF-QZTJIDSGSA-N
InChI=1S/C19H26Cl2N2O/c1-22(19(24)13-14-8-9-15(20)16(21)12-14)17-6-2-3-7-18(17)23-10-4-5-11-23/h8-9,12,17-18H,2-7,10-11,13H2,1H3/t17-,18-/m1/s1
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL3952 Sources: https://www.ncbi.nlm.nih.gov/pubmed/2822490 |
90.3 µM [Kd] |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
39K8JHE8XN
Created by
admin on Mon Mar 31 19:07:07 GMT 2025 , Edited by admin on Mon Mar 31 19:07:07 GMT 2025
|
PRIMARY | |||
|
67198-13-4
Created by
admin on Mon Mar 31 19:07:07 GMT 2025 , Edited by admin on Mon Mar 31 19:07:07 GMT 2025
|
PRIMARY | |||
|
73358
Created by
admin on Mon Mar 31 19:07:07 GMT 2025 , Edited by admin on Mon Mar 31 19:07:07 GMT 2025
|
PRIMARY | |||
|
3036289
Created by
admin on Mon Mar 31 19:07:07 GMT 2025 , Edited by admin on Mon Mar 31 19:07:07 GMT 2025
|
PRIMARY | |||
|
U-50488
Created by
admin on Mon Mar 31 19:07:07 GMT 2025 , Edited by admin on Mon Mar 31 19:07:07 GMT 2025
|
PRIMARY | |||
|
DTXSID50849401
Created by
admin on Mon Mar 31 19:07:07 GMT 2025 , Edited by admin on Mon Mar 31 19:07:07 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)